ScienceDex / Researcher record
Ming Yang
- Mucommune, Llc (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2025 | $2,178,184 | 2 | #5,828 |
| 2026 | $3,178,369 | 3 | #5,695 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20252 records
- FY2026 · selected3 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 80113373Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2025 through FY2026Career claims are limited to the years shown.
FY2026 award records by amount
NIH award records listing Ming Yang as a PI. Multi-PI records show the full award amount for context.
- 5R44CA310402-02R44Contact PISBIR: In vivo engineering of multifaceted B7H3.CAR-T cells for cellular immunotherapy of pancreatic ductal adenocarcinoma$1.1Maward amount
- 5R44CA306674-02R44Contact PISBIR: In vivo engineering of B7-H3.CAR-T cells for ovarian cancer therapy$1Maward amount
- 1R44AI197810-01R44Contact PISBIR: In vivo engineering of dual CD19/CD138 CAR-T cells for treatment of Systemic Lupus Erythematosus$1Maward amount
Award organization
Organizations that administered FY2026 awards listing Ming Yang as a PI.
FY2026 award administered by Mucommune, Llc (NC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardMucommune, Llc
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #5828
- 2026$5M Cumulative Funding